Literature DB >> 534044

Risk of intracranial aneurysm surgery in the good grade patient: early versus late operation.

D S Samson, R M Hodosh, W R Reid, C W Beyer, W K Clark.   

Abstract

To evaluate the risk of definitive intracranial microsurgical aneurysm obliteration as a function of the timing of the operative intervention, we retrospectively reviewed 106 consecutive patients in good clinical condition who underwent such surgery. The patients who were operated upon within the first 8 days of their most recent subarachnoid hemorrhage formed the "early" group; the patients operated upon between the 9th and 31st day were considered to have undergone "late" surgery. On the basis of their clinical outcome the patients were allocated to one of four outcome categories ("good," "fair," "death") both at the time of their hospital discharge and at their most recent clinical re-evaluation, a minimum of 6 months after discharge from the hospital. There was no significant difference in the operative mortality in each group (early surgery, 5%; late surgery, 4%); additionally, no significant difference was noted in the incidence of either intraoperative complications or postoperative morbidity. A suggestive but statistically insignificant increase in the incidence of postoperative cerebral ischemic events was seen in the "early" surgery group (8% vs. 4% for the "late" surgery group). The potential significance of these findings for the timing of intracranial aneurysm surgery is discussed.

Entities:  

Mesh:

Year:  1979        PMID: 534044     DOI: 10.1227/00006123-197910000-00002

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  10 in total

1.  Results of microsurgical management of ruptured intracranial aneurysms.

Authors:  S Fujiwara; T Matsubara; S Hachisuga
Journal:  Acta Neurochir (Wien)       Date:  1983       Impact factor: 2.216

2.  The International Cooperative study on timing of aneurysm surgery.

Authors:  N F Kassell; J C Torner
Journal:  Acta Neurochir (Wien)       Date:  1982       Impact factor: 2.216

3.  Early aneurysm surgery: a 7 year clinical practice report.

Authors:  J M Gilsbach; A G Harders; H R Eggert; M E Hornyak
Journal:  Acta Neurochir (Wien)       Date:  1988       Impact factor: 2.216

4.  Combined endovascular treatment for both intracranial aneurysm and symptomatic vasospasm.

Authors:  Yuichi Murayama; Joon K Song; Ken Uda; Y Pierre Gobin; Gary R Duckwiler; Satoshi Tateshima; Aman B Patel; Neil A Martin; Fernando Viñuela
Journal:  AJNR Am J Neuroradiol       Date:  2003-01       Impact factor: 3.825

5.  Shunt-dependent hydrocephalus after subarachnoid haemorrhage and aneurysm surgery: timing of surgery is not a risk factor.

Authors:  A Tapaninaho; J Hernesniemi; M Vapalahti; M Niskanen; A Kari; M Luukkonen; M Puranen
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

6.  A simple scoring system for accurate prediction of outcome within four days of a subarachnoid haemorrhage.

Authors:  C J Gerber; D A Lang; G Neil-Dwyer; P W Smith
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

7.  One-year outcome in early aneurysm surgery: a 14 years experience.

Authors:  J Hernesniemi; M Vapalahti; M Niskanen; A Tapaninaho; A Kari; M Luukkonen; M Puranen; T Saari; M Rajpar
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

8.  Surgical problems and pathophysiology in severe cases with ruptured aneurysm in the acute stage.

Authors:  N Yasui; Z Ito; H Ohta; A Suzuki
Journal:  Acta Neurochir (Wien)       Date:  1982       Impact factor: 2.216

9.  Surgical results of intracranial ruptured aneurysms in the acute stage.

Authors:  T Hotta; S Tokuda; M Nishiya; Y Tanaka; J Nakamura
Journal:  Acta Neurochir (Wien)       Date:  1982       Impact factor: 2.216

10.  Enhanced cisternal drainage and cerebral vasospasm in early aneurysm surgery.

Authors:  U Ito; H Tomita; S Yamazaki; Y Takada; Y Inaba
Journal:  Acta Neurochir (Wien)       Date:  1986       Impact factor: 2.216

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.